Lyophilization Services for Biopharmaceuticals: Global Industry Analysis and Forecast 2023-2028 Featuring ATTWILL Medical Solutions, Berkshire Sterile Manufacturing, Emergent BioSolutions, and More
14 juil. 2023 04h38 HE
|
Research and Markets
Dublin, July 14, 2023 (GLOBE NEWSWIRE) -- The Lyophilization Services for Biopharmaceuticals: Global Market Forecast to 2028 report has been added to ResearchAndMarkets.com's offering.The global...
Global Bispecific Antibodies Market to 2035: Players Include Akeso Biopharma, Amgen, Astrazeneca, Genmab and Immunocore
07 juil. 2023 07h18 HE
|
Research and Markets
Dublin, July 07, 2023 (GLOBE NEWSWIRE) -- The "Bispecific Antibodies Market 2023-2035" report has been added to ResearchAndMarkets.com's offering. This report features an extensive study of the...
Conjugation and Labeling Services Market 2023 - Antibodies Segment Accounted for the Largest Revenue Share | Reveals Latets InsightAce Survey
06 juil. 2023 07h35 HE
|
InsightAce Analytic Pvt. LTd.
Jersey City, NJ, July 06, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on “Global Conjugation and Labeling Services Market Size, Share...
Multispecific Antibody Development Clinical Trials Sales Market Size Insight
30 juin 2023 07h28 HE
|
KuicK Research
Delhi, June 30, 2023 (GLOBE NEWSWIRE) -- The development of multispecific antibodies, which have the potential to change the way cancer is treated, has been positively influenced by the commercial...
BioNTech und OncoC4 starten zulassungsrelevante Phase-3-Studie mit BNT316/ONC-392-Programm bei metastasiertem, nicht-kleinzelligem Lungenkarzinom
29 juin 2023 06h45 HE
|
BioNTech SE
Der Start der zulassungsrelevanten Phase-3-Studie für nicht-kleinzelliges Lungenkarzinom ist ein wichtiger erster Schritt in BioNTechs und OncoC4s strategischer Kollaboration, die im März 2023...
BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC
29 juin 2023 06h45 HE
|
BioNTech SE
Initiation of pivotal Phase 3 trial in non-small cell lung cancer (NSCLC) marks the first landmark in BioNTech’s and OncoC4’s strategic collaboration initiated in March 2023 with the aim to evaluate...
Monoclonal Antibodies Industry Analysis 2023: 180+ Companies, 230+ Drugs, Therapeutics Assessment, Inactive Pipeline Products, Unmet Needs
26 juin 2023 05h03 HE
|
Research and Markets
Dublin, June 26, 2023 (GLOBE NEWSWIRE) -- The "Monoclonal antibodies - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering. This report provides comprehensive...
Antibody Drug Conjugates Market to surpass USD 26.5 billion by 2032, says Global Market Insights Inc.
20 juin 2023 20h00 HE
|
Global Market Insights Inc.
Selbyville, Delaware, June 20, 2023 (GLOBE NEWSWIRE) -- Antibody Drug Conjugates Market size will cross USD 26.5 billion by 2032. Growing advancements in antibody engineering and conjugation...
[Latest] Global Tissue Diagnostics Market Size/Share Worth USD 125.63 Billion by 2032 at a 12.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
14 juin 2023 16h50 HE
|
Custom Market Insights
Austin, TX, USA, June 14, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Tissue Diagnostics Market Size, Trends and Insights By Application (Prostate...
Monoclonal Antibody Discovery and Research Report 2022-2032 - Growing Demand for Monoclonal Antibodies for Cancer Treatments
13 juin 2023 10h38 HE
|
Research and Markets
Dublin, June 13, 2023 (GLOBE NEWSWIRE) -- The "Monoclonal Antibody Discovery and Analysis Market Report 2022-2032" report has been added to ResearchAndMarkets.com's offering.Overall world revenue...